Previous Events

PERL Prize: Marcus Raichele Feb 20, 2014 from 03:00 PM to 05:00 PM MBRB G202,
Thursday Seminar Series: Mustafa Sahin Mar 13, 2014 from 12:30 PM to 01:30 PM 1131 Bioinformatics,
Thursday Seminar Series: Stephan Sanders Mar 18, 2014 from 12:30 PM to 01:30 PM 1131 Bioinformatics,
Thursday Seminar Series: Angelique Bordey Mar 27, 2014 from 12:30 PM to 01:30 PM 1131 Bioinformatics,
Thursday Seminar Series: Maria Lehtinen Apr 03, 2014 from 12:30 PM to 01:30 PM 1131 Bioinformatics,
Thursday Seminar Series: Lindsey Glickfeld Apr 10, 2014 from 12:30 PM to 01:30 PM 1131 Bioinformatics,
Thursday Seminar Series: Matt Dalva, PhD Apr 24, 2014 from 12:30 PM to 01:30 PM 1131 Bioinformatics,
Thursday Seminar Series: Jeffrey D. Rothstein, MD, PhD Jun 05, 2014 from 12:30 PM to 01:30 PM 1131 Bioinformatics,
Thursday Seminar Series: Vivian Gama and Dennis Sparta May 01, 2014 from 12:30 PM to 01:30 PM 1131 Bioinformatics,
Summer Lunch: 2 Jul 16, 2013 from 12:30 PM to 01:30 PM
Summer Lunch 3 Aug 06, 2013 from 12:30 PM to 01:30 PM
Thursday Seminar Series, Peter Penzes, PhD Oct 30, 2014 from 12:30 PM to 01:30 PM Bioinformatics Auditorium,
October 30, 12:30-1:30 PM, Bioinformatics Auditorium
Thursday Seminar Series, Mike Ehlers, MD, PhD Jan 08, 2015 from 12:30 PM to 01:30 PM 1131 Bioinformatics,
Tuesday Mini-Series-Heather Decot/Leah Townsend Feb 23, 2016 from 12:30 PM to 01:30 PM 124 Taylor Hall,
Tuesday Mini-Series-Nick Boyer Mar 22, 2016 from 12:30 PM to 01:30 PM 124 Taylor Hall,
Tuesday Mini-Series-Kelly Carstens/Sarah Schoenrock Apr 05, 2016 from 12:30 PM to 01:30 PM 124 Taylor Hall,
Tuesday Mini-Series Career Lunch: Aaron C. Gerlach, PhD May 06, 2014 from 12:30 PM to 01:30 PM 124 Taylor Hall,
Aaron Gerlach is a Senior Principal Scientist at Neusentis/Pfizer where he serves as a research project lead. He has accumulated over twenty years of ion channel experience in both academic and industry settings. For the past ten years his focus has been on small molecule ion channel drug discovery. In 2000 He earned his Ph.D. in Cell Biology and Physiology from the University of Pittsburgh where studied KCa3.1 channels as targets for the treatment of cystic fibrosis. Soon thereafter, he completed post-doctoral studies in neuroscience at that Vollum Institute at Oregon Health and Science University. In 2003, he joined Icagen, a biotech company focused on ion channel therapies, before joining Neusentis in 2011.
Tuesday Mini-Series-Anel Jaramillo/Elizabeth Andersen Feb 02, 2016 from 12:30 PM to 01:30 PM
Tuesday Mini-Series Jun 02, 2015 from 12:30 PM to 01:30 PM 1131 Bioinformatics,
Tuesday Mini-Series, presented by Katie Veleta
Tuesday Mini-Series Jun 09, 2015 from 12:30 PM to 01:30 PM 1131 Bioinformatics,
Tuesday Mini-Series, presented by Elizabeth Andersen and Mariko Weber